Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.23.3
Stock-based Compensation (Tables)
 12 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Summary of status of nonvested shares and stock option activity
The following table represents a summary of the status of the Company’s RSAs:
Restricted Stock Awards Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2022 28,546 $ 37.82 
Granted during year 2023 (a)
50 32.30 
Vested during year 2023 (b)
(11,037) 37.82 
Forfeited during year 2023 (19) 32.30 
Outstanding and expected to vest at 2023 (c)
17,540 $ 37.82 
a.The weighted average fair value of RSAs granted in year 2023 and 2022 was $32.30 and $37.82, respectively.
b.The total fair value of all RSAs vested in year 2023 and 2022 was $417 thousand and $214 thousand, respectively.
c.The weighted average remaining contractual term is 1.8 years and the aggregate intrinsic value of RSAs expected to vest is $438 thousand.
The following table represents a summary of the Company’s stock option activity:
Number of
Options		 Weighted
Average
Exercise
Price		 Weighted
Average
Remaining
Contractual
Term
(years)		 Aggregate
Intrinsic
Value
Outstanding – September 30, 2022 (a)
126,500 $ 33.78  0 —
Exercised during year 2023 — —  0 —
Forfeitures/expired during year 2023 (88,500) 33.96  0 —
Outstanding – September 30, 2023 38,000 $ 33.75  3.3 —
a.Includes 29,500 options which would vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40; 29,500 options which would vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45; and 29,500 options which would vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.